13.8
C
Manchester
Trending now
Sophos to Showcase AI-Native Cybersecurity Defense at…
Can new defense minister nominee’s US ties…
N. Korea, Russia complete construction of road…
Lee calls for partnership linking local content…
Rhino Commercial Roofing Expands Florida Commercial Roofing…
Rhino Commercial Roofers Expands Its Commercial Roofing…
Korean president announces initiative to invest $581…
Alaric Securities Recognized as Best Trading Platform…
Making Company Culture Memorable: MicroSourcing and MusoLingo…
QOMEX Summit 2026 to Bring Together the…
Home
News
Business
National
Press Release
Finanace
Search for:
Search
Primary Menu
Search for:
Search
Home
Business
FDA vaccine head will step down in April after string of controversial decisions
Business
FDA vaccine head will step down in April after string of controversial decisions
by
Douglas L. Grider
Vinay Prasad is leaving his post as director of the Center for Biologics Evaluation and Research.
previous post
FDA reversals leave investors worrying about the fates of other experimental drugs
next post
[TEST DRIVE] Renault Korea’s Filante set to take on Santa Fe, Sorento
Douglas L. Grider
Related posts
Dick’s Sporting Goods stock falls 15% as retailer misses expectations, cites ‘challenging’ footwear market
Douglas L. Grider
August 25, 2026
Paramount agrees to delay WBD acquisition to as late as June 2027 amid legal challenge
Douglas L. Grider
July 24, 2026
Pricey NFL, NBA ownership stakes are pushing investors to smaller leagues and driving valuations higher
Douglas L. Grider
April 30, 2026